X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
IPCL: Good show - Views on News from Equitymaster
 
 
  • PRINT
  • E-MAIL
  • FEEDBACK
  • A  A  A
  • Oct 13, 2003

    IPCL: Good show

    Reliance controlled IPCL, one of the major players in the petrochemicals segment, declared its 2QFY04 results today. The company registered a 20% bottomline growth on the back of a 7% increase in topline. The results, however, are relatively subdued as compared to the last few quarters wherein IPCL managed to post impressive topline and bottomline growth.

    (Rs m) 2QFY03 2QFY04 Change 1HFY03 1HFY04 Change
    Net sales 12,520 13,450 7.4% 21,080 27,000 28.1%
    Other Income 190 210 10.5% 280 420 50.0%
    Expenditure 10,000 10,430 4.3% 16,540 21,740 31.4%
    Operating Profit (EBDIT) 2,520 3,020 19.8% 4,540 5,260 15.9%
    Operating Profit Margin (%) 20.1% 22.5%   21.5% 19.5%  
    Interest 750 860 14.7% 1,800 1,670 -7.2%
    Depreciation 1,120 1,240 10.7% 2,240 2,370 5.8%
    Profit before Tax 840 1,130 34.5% 780 1,640 110.3%
    Extraordinary expenses - 90   - 1,310  
    Tax 390 500 28.2% 390 (600)  
    Profit after Tax/(Loss) 450 540 20.0% 390 930 138.5%
    Net profit margin (%) 3.6% 4.0%   1.9% 3.4%  
    No. of Shares 249.0 249.0   249.0 249.0  
    Diluted Earnings per share* 7.2 8.7   3.1 7.5  
    P/E Ratio         24.6  
    (*annualised)            

    Let us first consider the 2QFY04 results in brief. The topline increase seems largely a factor of sales volume growth. However, it was the control over expenditure, which helped the company improve its operating margins by 240 basis points. While the raw material contribution as a percentage of sales increased, the management was able to control the staff costs and other administrative expenses. The reduction in staff costs was also due to the fact that over the last two quarters, around 1,600 employees of the company have opted for VRS. The effect of this is visible in the form of extraordinary expenses of Rs 1.3 bn, a part of which (Rs 90 m) has been put to effect in the September quarter. Without the VRS effect, the PAT growth for 2QFY04 would have been at 40%.

    Now, as far as the performance of the company for the first half of the current fiscal is concerned, it has been splendid. It can be seen in the table above, the company’s bottomline surged 139% on the back of a 28% growth in topline. During this period, the company’s export of manufactured goods was higher by 44%. The other income component also increased by a hefty 50% on account of higher export benefits.

    However, the operating margins of the company have taken a hit in 1HFY04 on account of unfavorable petrochemical product prices during the June 2003 quarter. It should be noted that overall realisations had declined by about 9% in 1QFY04. Increase in raw material prices also pressurised operating margins. However, for the first half of the current fiscal, the interest outgo of the company reduced by 7% signifying that the company’s efforts at reducing debt have been yielding results.

    The company has informed that consequent to a change in the method of providing depreciation in respect of certain assets at the Vadodara Complex, the additional depreciation charge of Rs 2.1 bn has been written off against the general reserve. Further, the company has also stated that as per the new accounting standard (AS-26) regarding valuation of intangible assets, an amount of Rs 220 m, being the balance of unamortised miscellaneous expenditure, has been also written off against the general reserve. The effect of these adjustments would lead to a reduction in the book value of the stock.

    At Rs 184, the stock is trading at P/E multiple of almost 25x its 1HFY04 annualised earnings. While the valuations are on the higher side of the petrochem spectrum, the outlook given by the management points to the current upturn in the petrochemical cycle sustaining, which would be beneficial for the company. Improved polymer prices and synergies with Reliance are likely to benefit IPCL in terms of cost rationalisation.

     

     

    Equitymaster requests your view! Post a comment on "IPCL: Good show". Click here!

      
     

    More Views on News

    Sorry! There are no related views on news for this company/sector.

    Most Popular

    A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

    Aug 10, 2017

    Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

    The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

    Aug 10, 2017

    Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    Bitcoin Continues Stellar Rise(Chart Of The Day)

    Aug 10, 2017

    Bitcoin hits an all-time high, is there more upside left?

    5 Steps To Become Financially Independent(Outside View)

    Aug 16, 2017

    Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

    More
    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
     

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms

    TRACK IPCL

    MARKET STATS